Ipca Laboratories Dividend Details
Record Date
05-Aug-2025
Dividends Date
05-Aug-2025
Ex Date
05-Aug-2025
Dividend Type
Equity Share
Dividend Per Share
₹2.00
The Ipca Laboratories has declared a Equity Share dividend of ₹2.00 per share. Investors should note the Ipca Laboratories dividend 2026 record date is 05-Aug-2025, and the Ipca Laboratories ex-dividend date is 05-Aug-2025 to confirm eligibility for the payout. This move underscores the Ipca Laboratories ongoing efforts to enhance shareholder value through regular dividend distributions.
Ipca Laboratories Dividend History
| Record Date | Dividend Per Share | Dividend Type | Ex-Date |
|---|---|---|---|
| 05-Aug-2025 | ₹2.00 | Equity Share | 05-Aug-2025 |
Upcoming Dividends by Indian Companies
View More| Company | Dividends Ratio | Announcement | Record Date | Dividends Date |
|---|---|---|---|---|
| Engineers India Ltd. | 0 | 17-Feb-2026 | 06-Mar-2026 | 06-Mar-2026 |
| SBI Life Insurance Company Ltd. | 0.27 | 23-Feb-2026 | 06-Mar-2026 | 06-Mar-2026 |
Ipca Laboratories Dividend FAQs
The latest dividend declared by Ipca Laboratories is of 2 per share for the financial year as announced on 05-Aug-2025.
Registered shareholders who own Ipca Laboratories’s shares on or before the record date of 05-Aug-2025 set by the company are eligible to receive the dividend. You will not be entitled to the payout if you purchase shares on or after the ex-dividend date of 05-Aug-2025.
You can expect to receive Ipca Laboratories’s dividend in your bank account linked to your Demat account within 25 to 45 business days after the record date of 05-Aug-2025. The record date is when Ipca Laboratories identifies eligible shareholders for the dividend payment.
The annual dividend paid by Ipca Laboratories varies according to its financial performance and dividend policy. Generally, companies in different sectors exhibit varying dividend yields. To determine Ipca Laboratories's specific annual dividend, it’s advisable to consult the company's official investor relations website or recent financial statements.
